Data search
Results for MligTC455_46693
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_46693 | 3882 | 80.87 | Mlig455_025430 | Neo: - Age: - |
QRICH2 | Mlig455_025430 {REF} {Length: 1972} {Human: ENSG00000129646, QRICH2, glutamine rich 2, [Score=52.8, Expect=7e-07]} {RNA1509_26782, RNA1509_3289, RNA1509_36655} {RNA1310_19397.2, RNA1509_26782, RNA1509_3289, RNA1509_36655} {RNA1509_26782, RNA1509_3289, RNA1509_36655, RNA815_16071.1} |
Cumulative graph for MligTC455_46693
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.594 | 6.42 | 0.32308 | 0.97267 | |
| RegionR2 | -0.172 | 6.42 | 0.61875 | 0.96385 | |
| RegionR3 | -0.409 | 6.42 | 0.17966 | 0.70982 | |
| RegionR4 | -0.511 | 6.42 | 0.13878 | 0.37991 | |
| RegionR5 | 0.865 | 6.42 | 0.00127 | 0.01231 | |
| RegionR6 | 0.131 | 6.42 | 0.64952 | 1.00000 | |
| RegionR7 | 0.273 | 6.42 | 0.38319 | 1.00000 | |
| RegionR8 | 0.417 | 6.42 | 0.23751 | 0.85398 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.592 | 6.42 | 0.41948 | 1.00000 | |
| RegenerationR2 | 0.504 | 6.42 | 0.14584 | 0.57740 | |
| RegenerationR3 | 0.086 | 6.42 | 0.81513 | 0.98627 | |
| RegenerationR4 | 0.352 | 6.42 | 0.34717 | 0.77751 | |
| RegenerationR5 | 0.013 | 6.42 | 0.97028 | 1.00000 | |
| RegenerationR6 | -0.229 | 6.42 | 0.53687 | 0.83108 | |
| RegenerationBL | 0.422 | 6.42 | 0.19647 | 0.53295 | |
| RegenerationTP | 0.023 | 6.42 | 0.94806 | 1.00000 |
Genes with expression patterns similar to MligTC455_46693
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_46693 | 3882 | 80.87 | Mlig455_025430 | Neo: - Age: - |
QRICH2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_025430 {REF} {Length: 1972} {Human: ENSG00000129646, QRICH2, glutamine rich 2, [Score=52.8, Expect=7e-07]} {RNA1509_26782, RNA1509_3289, RNA1509_36655} {RNA1310_19397.2, RNA1509_26782, RNA1509_3289, RNA1509_36655} {RNA1509_26782, RNA1509_3289, RNA1509_36655, RNA815_16071.1} |
| 2. | MligTC455_29031 | 1685 | 35.11 | Mlig455_007131 | Neo: - Age: - |
A2M | 0.961 | - | - | - | 0.961 | - | - | Mlig455_007131 {REF} {Length: 5511} {Pfam: A-macroglobulin TED domain [PF07678.16, score=106.5]; Alpha-2-macroglobulin bait region domain [PF07703.16, score=49.3]; A-macroglobulin receptor binding domain [PF07677.16, score=39.7]; Alpha-2-macroglobulin family [PF00207.24, score=34.8]} {Human: ENSG00000175899, A2M, alpha-2-macroglobulin, [Score=119, Expect=3e-26]} {Mouse: ENSMUSG00000046186, Cd109, CD109 antigen, [Score=169, Expect=9e-42]} {Dmel: FBgn0267488, Mcr, Macroglobulin complement-related, [Score=477, Expect=4e-143]} {Smed: dd_Smed_v6_3070_0_1, dd_Smed_v6_3070_0_1, [Score=771, Expect=0.0]} {RNA1509_1731, RNA1509_41707} {RNA1310_1024.2, RNA1509_1731, RNA1509_41707} {RNA1509_1731, RNA1509_41707, RNA815_332} |
| 3. | MligTC455_53909 | 765 | 15.95 | Mlig455_034369 | Neo: - Age: - Regeneration-upregulated BL: 3.468 Regeneration-enriched BL: 3.468 |
SBSN | 0.959 | - | - | - | 0.959 | - | - | Mlig455_034369 {REF} {Length: 2517} {Pfam: Apolipoprotein A1/A4/E domain [PF01442.20, score=20.1]} {Human: ENSG00000189001, SBSN, suprabasin, [Score=81.6, Expect=1e-15]} {Mouse: ENSMUSG00000040838, Gm11639, predicted gene 11639, [Score=71.2, Expect=2e-12]} {Celegans: WBGene00001113, dur-1, Dauer Up-Regulated, [Score=120, Expect=3e-28]} {RNA1509_53891} {RNA1310_42336} {RNA815_24531} |
| 4. | MligTC455_47051 | 3486 | 72.62 | Mlig455_009503 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.389 Regeneration-upregulated BL: 1.613 Regeneration-enriched BL: 1.613 |
0.957 | - | - | - | 0.957 | - | - | Mlig455_009503 {REF} {Length: 2503} {Pfam: F5/8 type C domain [PF00754.27, score=79.3]; Sad1 / UNC-like C-terminal [PF07738.15, score=27.0]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_20089} {RNA1310_38721} {RNA815_6421.1} | |
| 5. | MligTC455_27989 | 137 | 2.85 | Mlig455_015923 | Neo: - Age: Down-Up-Down |
SVOP | 0.956 | - | - | - | 0.956 | - | - | Mlig455_015923 {REF} {Length: 2666} {Pfam: Major Facilitator Superfamily [PF07690.18, score=112.7]; Sugar (and other) transporter [PF00083.26, score=104.9]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=229, Expect=7e-68]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=221, Expect=3e-65]} {Dmel: FBgn0051272, CG31272, [Score=71.2, Expect=9e-13]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=198, Expect=5e-57]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=251, Expect=2e-77]} {RNA1310_58770} {RNA815_42378} |
| 6. | MligTC455_33236 | 8060 | 167.92 | Mlig455_015463, Mlig455_040797, Mlig455_064637 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.506 Region-enriched R5: 2.203/0.00002 |
0.956 | - | - | - | - | - | 0.956 | Mlig455_015463 {REF} {Length: 1322} {Pfam: FLYWCH zinc finger domain [PF04500.18, score=33.6]} {Smed: dd_Smed_v6_40199_0_1, dd_Smed_v6_40199_0_1, [Score=47.0, Expect=2e-06]} {RNA1310_56368} Mlig455_040797 {REF} {Length: 1118} {RNA1509_12518, RNA1509_2016, RNA1509_50739} {RNA1310_34520.2, RNA1509_12518, RNA1509_2016, RNA1509_50739} {RNA1509_12518, RNA1509_2016, RNA1509_50739, RNA815_16036} Mlig455_064637 {REF} {Length: 1163} {RNA1509_12518, RNA1509_55028} {RNA1310_34520.1, RNA1509_55028} {RNA1509_55028, RNA815_16036} |
|
| 7. | MligTC455_48224 | 130 | 2.7 | Mlig455_033977 | Neo: - |
GLRA3 | 0.954 | - | - | - | 0.954 | - | - | Mlig455_033977 {REF} {Length: 2696} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=151.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=128.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=266, Expect=7e-83]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=266, Expect=4e-83]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=265, Expect=1e-82]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=259, Expect=8e-81]; ENSG00000166206, GABRB3, gamma-aminobutyric acid type A receptor beta3 subunit, [Score=253, Expect=4e-78]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=271, Expect=9e-85]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=266, Expect=3e-83]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=264, Expect=2e-82]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=260, Expect=6e-81]} {Dmel: FBgn0024963, GluClalpha, [Score=252, Expect=6e-78]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [RH, Score=244, Expect=2e-74]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=221, Expect=4e-66]} {RNA1310_13574.1} {RNA815_10577.1} |
Berezikov Lab - 2020-2021 © ERIBA